These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 4595312

  • 1. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW, Pimm MV.
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract] [Full Text] [Related]

  • 2. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW, Pimm MV.
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract] [Full Text] [Related]

  • 3. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L, Hunter N, Withers HR.
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract] [Full Text] [Related]

  • 4. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G, Halle-Pannenko O, Bourut C.
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract] [Full Text] [Related]

  • 5. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO.
    Johns Hopkins Med J Suppl; 1974 Dec; 3():51-60. PubMed ID: 4370816
    [No Abstract] [Full Text] [Related]

  • 6. BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
    Baldwin RW, Pimm MV.
    Br J Cancer; 1973 Jan; 27(1):48-54. PubMed ID: 4686177
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Mycobacterium bovis BCG-Praha on the growth of transplanted Daels' sarcoma in guinea-pigs.
    Schwartz E.
    Neoplasma; 1973 Jan; 20(4):375-86. PubMed ID: 4580793
    [No Abstract] [Full Text] [Related]

  • 9. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW, Rudenstam CM, Alexander P.
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract] [Full Text] [Related]

  • 10. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I, Weiss DW, Robinson E, Cohen D, Adelberg MG, Mekori T, Haber M.
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma.
    Eilber FR, Holmes EC, Morton DL.
    J Natl Cancer Inst; 1971 Apr; 46(4):803-8. PubMed ID: 5573770
    [No Abstract] [Full Text] [Related]

  • 12. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R.
    Johns Hopkins Med J Suppl; 1974 Apr; 3():333-40. PubMed ID: 4609353
    [No Abstract] [Full Text] [Related]

  • 13. Regression of polyoma tumor metastasis by combined unblocking and BCG treatment--correlation with induced alterations in tumor immunity status.
    Bansal SC, Sjögren HO.
    Int J Cancer; 1973 Jul 15; 12(1):179-93. PubMed ID: 4597859
    [No Abstract] [Full Text] [Related]

  • 14. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL, Rios A.
    Natl Cancer Inst Monogr; 1973 Dec 15; 39():57-68. PubMed ID: 4595327
    [No Abstract] [Full Text] [Related]

  • 15. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr 15; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M, Lawrence N, Nisbet NW.
    Biomedicine; 1976 Jan 15; 24(1):26-31. PubMed ID: 773443
    [Abstract] [Full Text] [Related]

  • 17. BCG and cancer (first of two parts).
    Bast RC, Zbar B, Borsos T, Rapp HJ.
    N Engl J Med; 1974 Jun 20; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract] [Full Text] [Related]

  • 18. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M, Lawrence N, Nisbet NW.
    Int J Cancer; 1975 Jun 15; 15(6):897-911. PubMed ID: 1150345
    [Abstract] [Full Text] [Related]

  • 19. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E.
    J Natl Cancer Inst; 1975 May 15; 54(5):1189-97. PubMed ID: 805254
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS, Bartlett GL.
    J Natl Cancer Inst; 1972 Nov 15; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.